Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-31 @ 10:37 PM
Study NCT ID:
NCT01495702
Status:
COMPLETED
Last Update Posted:
2016-01-07
First Post:
2011-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-14
First Submit QC Date:
None
Study First Post Date:
2011-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-31
Results First Submit QC Date:
None
Results First Post Date:
2015-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-08-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-12-01
Last Update Post Date:
2016-01-07
Last Update Post Date Type:
ESTIMATED